Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,268 GBX | +0.16% | +3.59% | +6.30% |
03:38pm | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
10:50am | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
Evolution of the average Target Price on AstraZeneca PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AstraZeneca PLC
JPMORGAN | James Gordon |
Deutsche Bank Securities | |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
BARCLAYS | Emily Field |
UBS | Matthew Weston |
alphavalue | Abhishek Raval |
Bernstein | |
B. Riley | |
RBC Capital Markets | |
Berenberg Bank | |
BERENBERG | Luisa Hector |
JEFFERIES | Peter Welford |
DZ Bank | |
BMO Capital | |
Stifel Nicolaus | |
Jefferies & Co. | |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
Argus | |
Morgan Stanley | |
GOLDMAN SACHS | Keyur Parekh |
Bank of America Securities/Merrill Lynch | |
Danske Bank Group | |
Kepler Capital Markets | |
Kepler Cheuvreux | |
DEUTSCHE BANK | Emmanuel Papadakis |
SVB Leerink | |
Bryan, Garnier & Co. | |
Societe Generale | |
Liberum Capital | |
ODDO BHF | |
BANK OF AMERICA (BOFA) | Sachin Jain |
EPS Revisions
- Stock Market
- Equities
- AZN Stock
- Consensus AstraZeneca PLC